Journal ArticleOpen Access
Cost-Effectiveness Analysis of Combination Therapies for Visceral Leishmaniasis in the Indian Subcontinent
Authors
Author Affiliations
Instituut voor Tropische Geneeskunde, Drugs for Neglected Diseases Initiative, University of Oxford, World Health Organization, ...
Published InPLoS neglected tropical diseases
Year2010
Citations130
Abstract
BACKGROUND: Visceral leishmaniasis is a systemic parasitic disease that is fatal unless treated. We assessed the cost and cost-effectiveness of alternative strategies for the treatment of visceral leishmaniasis in the Indian subcontinent. In particular we examined whether combination therapies are a cost-effective alternative compared to monotherapies. METHODS AND FINDINGS: We assessed the cost-effectiveness of all possible mono- and combination therapies for the treatment of visceral leishmaniasis in the Indian subcontinent (India, Nepal and Bangladesh) from a societal perspective using a decision analytical model based on a decision tree. Primary data collected in each country was combined with data from the literature and an expert poll (Delphi method). The cost per patient treated and average and incremental cost-effectiveness ratios expressed as…
View at Publisher
BORR does not host full-text PDFs. The button above takes you to the original publisher.